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Abstract 
 
Variation in response to vaccination, particularly in vulnerable groups, provides a strong 
rationale for developing vaccine adjuvants. If there were consistent diurnal variation in 
immune response this could inform a simple intervention for enhancing vaccine efficacy. 
Data from two studies are presented examining morning versus afternoon vaccine 
administration; in the first, hepatitis A vaccine was administered to young adults, and in the 
second, influenza vaccine to older community-based adults. Men, but not women, vaccinated 
in the morning mounted a better peak antibody response to both hepatitis A and the A/Panama 
influenza strain. These results indicate that it would be worthwhile testing this effect in a large 
randomised control trial with vaccination during time periods representing the extremes of 
hormonal and cytokine diurnal rhythms.  
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Vaccination is a valuable strategy to reduce morbidity and mortality from a variety of 
diseases.  Most modern non-replicating purified subunit or synthetic viral vaccines have 
limited immunogenicity on their own (Edelman, 1980), resulting in inadequate antibody 
production and disease protection, particularly among vulnerable groups such as older adults 
(Hodes, 1997).  Consequently, substantial resource has gone into researching vaccine 
adjuvants; usually aluminium compounds which can give rise to adverse side effects (Gupta 
& Siber, 1995).  Even with adjuvant help, there is considerable variation in vaccination 
response (Jefferson, 2006).  This could arise from a variety of vaccine-related factors, such as 
dose (Lynn, et al., 2004) and delivery needle size (Diggle, Deeks, & Pollard, 2006).  
However, less attention has been paid to the circumstances surrounding vaccine 
administration, such as time of day.  In an early study, individuals given an attenuated 
Venezualan equine encephalomyelitis vaccine at 8am exhibited peak antibody titres four days 
earlier than those vaccinated at 8pm (Feigin, Jaeger, McKinney, & Alevizatos, 1967), 
whereas administration of a hepatitis B vaccine in the afternoon between 1 and 3pm induced 
higher antibody levels than morning injections between 7.30 and 9 am (Pollman & Pollman, 
1988).  Finally, a study of influenza vaccination in this context reported that the peak 
response to the A/Philippines strain occurred when the vaccine was administered between 
11.00am and 1.00pm (Langlois, Smolensky, Glezen, & Keitel, 1995).  Taken together, these 
preliminary results provide little guidance as to the best time to vaccinate.  Achieving a better 
immune response to vaccination is clinically important, particularly for disease susceptibility 
and mortality in older adults (Crofts, et al., 2003).  Accordingly, if consistent diurnal 
variations in antibody response to vaccination were to emerge from further study, this could 
inform a simple and realisable means of improving disease protection (Petrovsky, McNair, & 
Harrison, 1998).  Consequently, we present analyses of the impact of time of day of 
vaccination on antibody response from two separate studies.  The first study assessed the 
response to a hepatitis A vaccine in young healthy adults, and the second examined responses 
to the annual influenza vaccination in older community-based adults. 
 
Method 
 
Participants 
 
In Study 1, participants were 75 (34 men) University of Birmingham students with a mean 
age of 22.9 (SD = 3.89) years.  In terms of ethnicity, 89% described themselves as “white,” 
2.7% as “Asian,” 1.3% as “black,” and 7% as “other”.  None of the participants were 
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suffering from a current acute infection, chronic medical condition, or immune disorder.  
Ninety-five percent reported being non-smokers.  For Study 2, data were available for 89 
older adults (38 men) recruited from five medical practices in Birmingham, UK for a study on 
the associations between psychosocial factors and the antibody response to influenza 
vaccination, reported elsewhere (Phillips, et al., 2006).  All participants were aged 65 years or 
older and had no acute infection or known current immune disorder.  Participants’ mean age 
at entry to the study was 73.1 (SD = 5.49) years.  All but one described themselves as 
“white”: one described themself as “black”, and one as “other”.  Ninety-one per cent were 
non-smokers. 
 
Procedures 
 
At an initial session, participants provided a venous blood sample before vaccination to 
determine baseline antibody status.  In study 1, participants were randomly allocated to either 
a morning (10am to 12pm; n = 39) or early evening (4pm to 6pm; n = 36) vaccination session; 
although given academic timetabling practicalities, about 30% of participants could only 
attend a specific session.  They were vaccinated with the hepatitis A vaccine (HAVRIX™; 
Glaxo SmithKline).  In study 2, the baseline session was when older adults were attending 
their medical practice for the annual influenza vaccination.  Time of day of vaccination was 
therefore an opportunistic variable.  These data were collated following completion of the 
study using appointment records and the researcher’s own files.  A binary am/pm variable 
was created; to provide a clear temporal division yet retain sufficient power to detect effects, 
participants vaccinated between 11am and 1pm were excluded.  Fifty-nine participants 
vaccinated in the morning between 8am and 11am, and 30 in the afternoon between 1pm and 
4pm.  The 2003-04 influenza vaccine, administered by a nurse, contained three viral strains: 
A/New Caledonia/20/99; A/Panama/2007/99; and B/Shangdong/7/97.  In both studies the 
follow-up blood sampling took place approximately one month later (younger adults mean = 
31.3; SD = 3.10 days; older adults mean = 28.6; SD = 2.91 days).   
 
Sample preparation and immunological assays 
 
Serum was assessed for hepatitis A antibody titres using a commercial quantitative assay, 
Enzygnost® Anti-HAV (Dade Behring, Germany).  Anti-influenza antibody titers were 
measured by the serology laboratory of Glaxo Smith Kline Beecham at Dresden, Germany, 
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using a haemagglutination inhibition test as described in the World Health Organisation 
Manual on animal influenza diagnosis and surveillance.   
 
Data analysis 
 
Antibody titres were log10 transformed due to their marked variability.  To examine time 
of day effects on antibody response, ANCOVA was applied using the log antibody titer at 
one-month follow-up to each antigen as the dependent variable.  Time of day of vaccination 
was entered as a fixed factor.  Given that two previous studies by our group have observed 
sex differences in the response to vaccination (see Edwards, et al., 2006; Phillips, Burns, 
Carroll, Ring, & Drayson, 2005), sex was also analysed as a fixed factor.  Baseline titre was 
entered as a covariate.  Effect sizes are reported as η2.  High negative life events exposure in 
the hepatitis A study was associated with a poorer vaccination response (Gallagher, Carroll, & 
Phillips, 2007), so the total number of life events was added as a covariate in subsequent 
analyses of the younger sample.  Since older age and having experienced bereavement in the 
past year had a negative effect on antibody response in the older sample (Phillips, et al., 
2006), age and bereavement served as further covariates in subsequent analyses.  Finally, 
whether or not participants mounted a two-fold increase in antibody titre from baseline was 
calculated to provide an estimate of the clinical implications of any diurnal variation in 
vaccine response. 
 
Results 
 
Vaccination response 
 
Participants responded with a significant increase in antibody titre for all four antigens 
from baseline to one month (see Table 1).   
 
Associations between time of day of vaccination and antibody response 
 
For hepatitis A, there was no time of day or sex main effect on antibody response.  There 
was, however, a significant sex x time of day interaction, F(1,70) = 6.74, p = .01, η2 = .088: 
men exhibited a better antibody response to a morning than an afternoon vaccination, whereas 
women tended, if anything, to mount a better antibody response to the afternoon vaccination.  
In the older adults, our analyses again failed to detect significant time of day or sex main 
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effects on the response to any of the three viral strains.  However, for A/Panama, there was a 
sex x time of vaccination interaction effect, F(1,84) = 5.93, p = .02, η2 = .066: as before, men, 
but not women, mounted a better antibody response to morning vaccination.   
 
Associations between time of day of vaccination and antibody response adjusting for 
covariates 
 
The above analysis for hepatitis A was repeated adjusting for total life events exposure.  
Again, there was a significant sex x time of day interaction, F(1,69) = 6.56, p = .01, η2 = .087.  
In the older adults, repeat analysis included age and whether or not the participant had 
experienced bereavement as covariates.  The sex x time of vaccination interaction for 
A/Panama remained significant, F(1,82) = 7.12, p = .009, η2 = .080.  These effects are 
illustrated in Figure 1 using estimated marginal means. 
 
Sex differences in time of day and vaccination response associations 
 
In order to examine the sex x time of day interaction effects further, separate ANCOVAs 
were conducted for men and women.  For the response to hepatitis A, the difference in 
antibody response with time of day of vaccination was statistically significant only in the 
men, F(1,31) = 5.86, p = .02, η2 = .159.  For the influenza A/Panama strain in the older adults, 
men again responded better in the morning, F(1,35) = 5.45, p = .03, η2 = .135.  These 
correspond to medium to large effects and remained significant following adjustment for the 
relevant covariates.  Although women appeared to show better antibody responses following 
afternoon vaccination, the difference between morning and afternoon in women was not 
statistically significant, for hepatitis A, F(1,38) = 1.81, p = .19, η2 = .045, and A/Panama, 
F(1,48) = 0.84, p = .36, η2 = .017.  For hepatitis A, 87% of men vaccinated in the morning 
showed a two-fold response, in comparison to 47% of men vaccinated in the afternoon.  For 
influenza, 41% of men showed a two-fold response to the A/Panama strain when vaccinated 
in the morning versus 24% of men vaccinated in the afternoon.   
 
Discussion 
 
Previous research on the effects of time of day of vaccine administration on antibody 
response is limited and inconsistent (Feigin, Jaeger, McKinney, & Alevizatos, 1967; Langlois, 
Smolensky, Glezen, & Keitel, 1995; Pollman & Pollman, 1988).  Data from the current 
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studies consistently demonstrated an interaction between sex and time of day of vaccination; 
men vaccinated in the morning exhibited a stronger antibody response to hepatitis A and the 
A/Panama influenza strain than men vaccinated in the afternoon.  Almost twice as many men 
showed a two-fold increase in antibody titre when vaccinated in the morning as opposed to 
the afternoon.  Of the three strains that make up the influenza vaccine, A/Panama appears to 
be particularly susceptible to exogenous influence (see Edwards, et al., 2006; Phillips, Burns, 
Carroll, Ring, & Drayson, 2005; Phillips, et al., 2006).  The mechanism underlying this effect 
remains unclear.  However, cytokines and cortisol exhibit diurnal rhythmicity (Petrovsky, 
McNair, & Harrison, 1998), and both are potent regulators of immune function (Cooper, 
Duckett, Petts, & Penny, 1979; Dhabhar, 2002).  Although there is little evidence of sex 
differences in such diurnal rhythms (Edwards, Evans, Hucklebridge, & Clow, 2001; Hansen, 
Garde, Christensen, Eller, & Netterstrom, 2001), it is possible that cytokines and cortisol 
variations have different consequences for immunity in men and women. 
The present study has several limitations.  First, participants were not fully randomised to 
morning or afternoon vaccination sessions, making it difficult to discount completely 
alternative explanations for the effects found.  For example, it is possible that men attending 
the earlier vaccination sessions were less distressed or, in the influenza study, were also 
younger.  However, it is difficult to see why bias of this sort would be specific to men.  In 
addition, adjustment for measures of stress in both samples and age in the older sample did 
not change the outcomes.  Further, for the majority of participants in the older sample, time of 
appointment was not optional but was allocated by their medical practice, and in the younger 
sample allocation was as random as possible within academic timetable constraints.  
Nevertheless, residual confounding by either unmeasured factors or variables measured with 
error must remain a possibility (Christenfeld, Sloan, Carroll, & Greenland, 2004).  Second, as 
the older sample analysed here were part of a larger study examining the effects of 
psychosocial factors on vaccination, precise data on time of vaccine administration were not 
collected for all participants, meaning that only a dichotomous am/pm variable could be 
sensibly derived. This variable is clearly a crude reflection of specific timing of vaccination. 
Nevertheless, the introduction of time-specific vaccination as an intervention would need to 
be compatible with the organisation of health services. In this context the contrast of a 
morning-based with an afternoon-based service has some ecological validity.  Analyses still 
yielded significant temporal effects on antibody response for men when the younger sample 
were grouped by hour of vaccination and when the group vaccinated between 11am and 1pm 
in the older sample was included.  However, the sample sizes in these finer grain analyses 
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were such (N = 7 in some cases) that we are reluctant to draw inferences beyond our 
conclusion that it would appear to be better for men to be vaccinated earlier rather than later.  
Third, although we have posited that a differential impact of cortisol or cytokine variations on 
men and women’s immunity may underlie the present findings, in the absence of data such 
explanations are necessarily speculative.   
Our findings should be regarded as tentative.  Nevertheless, the effect sizes were medium 
to large in statistical terms.  At a population level, titre variations of this magnitude could 
have clinical significance.  At the very least, our results suggest that a large scale properly 
randomised control trial is worth pursuing.  If these effects were replicated, they would have 
major implications for the temporal scheduling of vaccination programmes and could provide 
a very cost effective vaccine adjuvant. 
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Table 1. Geometric Mean (95% Confidence Intervals) Antibody Titers at Initial Baseline and at the 
One Month Follow-up. 
 
 
Viral Strain 
 
Pre-vaccination 
 
One-month 
Follow-up 
 
ANOVA 
 (p<.001) 
 
Hepatitis A 
 
37.15 
 
199.53 
 
F(1,74) = 166.66 
 (2 – 575) (23 – 1698) p <.001, η2 = .693 
 
A/New Caledonia/20/99 
 
38.02 
 
64.57 
 
F(1,88) = 24.96 
 (4-407) (8-537) p <.001, η2 = .221 
A/Panama/2007/99 56.23 95.50 F(1,88) = 36.39 
 (4-724) (8-1122) p <.001, η2 = .293 
B/Shangdong/7/97 57.54 104.71 F(1,88) = 40.76 
 (5-631) (11-955) p <.001, η2 = .317 
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Figure 1: Associations between time of day of vaccination and antibody response.  
 
 
 
 
 
 
 
 
 
